Chronic Myeloid Leukemia Drugs Market - Global
Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Chronic
Myeloid Leukemia (CML) is a type of blood cancer caused by uncontrolled growth
of the cells in bone marrow. CML is a type of myeloproliferative disease which
is characterized by the chromosomal translocation. Patients suffering from CML
show increased susceptibility to infections, thrombocytopenia, anemia and may
also have enlarged spleen which causes pain on the left side.
To Read The Complete Report with
TOC:-
Incidence
rate of CML is high in men and is the second most common type of cancer
occurring in male adults. Women who are above 50 years in age are expected to
suffer from this chronic disease. Treatment for CML depends on the phase of the
disease that can be chronic, accelerated or the blast phase and the treatments
for CML include chemotherapy, stem cell transplants and biologic therapies.
Drugs available in the market are tyrosine Kinase inhibitor.
About
90% of the CML cases occur in the middle age and progresses with the aging.
Therefore, CML drugs market is poised to grow with the rise in aging population
and increasing incidences of CML. Drugs such as Gleevec (Imatinib Mesylate),
Bosulif (Bosutinib), Sprycel (Dasatinib), Iclusig (Ponatinib Hydrochloride) and
others are commercially available for the treatment of CML. These drugs have
improved the survival rate of the patient by 92.5%. Gleevec was the first CML
drug introduced in 2001, since then there has been a revolutionary change in
the quality life of patient as compared to the former chemotherapy drugs.
One
of the major risk factor associated with occurrence of CML is the exposure to
ionizing radiations. For instance cases of CML were mainly indicated in the
regions where people were exposed to atomic bombings (Hiroshima and Nagasaki).
Recently in 2012, Ponatinib received FDA approval for the treatment of CML.
Further, players in the market are adopting various growth strategies such as
mergers and acquisitions, new product launches, innovative product pipeline to
remain competitive. Some of the market players in this industry are Novartis
Pharmaceuticals, Bristol-Myers Squibb, Ariad Pharmaceuticals, Inc, Pfizer and
others.
To Buy a Copy Of This Report:-
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
·
North
America
·
Asia
Pacific
·
Europe
·
Rest of the World
Contact:-
M/s
Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment